VolitionRx Could Be a Game Changer in Cancer Detection

VolitionRx Could Be A Game Changer In Cancer Detection
Filed under: dual diagnosis treatment program

As such, the earlier the diagnosis and initiation of appropriate treatment, the better likelihood of improved patient outcomes. Current cancer diagnosis and screening methods leave substantial room for improvement in terms of accuracy, cost, patient …
{Source}

Lexicon Advances LX4211 in Type 1 Diabetes Phase 2 Trial
Filed under: dual diagnosis treatment program

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease. Lexicon currently has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications, …
{Source}